Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller, EB Mikulik, AM Dauki… - Pharmacogenomics …, 2016 - Taylor & Francis
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …
被引用次数：100 相关文章
[HTML] nih.gov

[HTML][HTML] Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller, EB Mikulik, AM Dauki… - Pharmacogenomics …, 2016 - ncbi.nlm.nih.gov
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …

Pharmacogenomics of statins: understanding susceptibility to adverse effects.

JP Kitzmiller, EB Mikulik, AM Dauki… - Pharmacogenomics …, 2020 - go.gale.com
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …

Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller, EB Mikulik, AM Dauki… - Pharmacogenomics …, 2016 - dovepress.com
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …

Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller, EB Mikulik, AM Dauki… - Pharmacogenomics …, 2016 - search.proquest.com
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …
[PDF] scienceopen.com

[PDF][PDF] Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller - Pharmacogenomics and Personalized Medicine, 2016 - scienceopen.com
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …

Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller, EB Mikulik, AM Dauki… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …
[PDF] academia.edu

[PDF][PDF] Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller - Pharmacogenomics and Personalized Medicine, 2016 - academia.edu
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …
[PDF] semanticscholar.org

[PDF][PDF] Pharmacogenomics of statins: understanding susceptibility to adverse effects

JP Kitzmiller - Pharmacogenomics and Personalized …, 2016 - pdfs.semanticscholar.org
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …

Pharmacogenomics of statins: Understanding susceptibility to adverse effects

JP Kitzmiller, EB Mikulik, AM Dauki… - …, 2016 - ohiostate.elsevierpure.com
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …